Pharmacovigilance Centre established at DUHS

Print

 Pharmacovigilance Centre
established at DUHS

KARACHI: Dow University of Health Sciences in collaboration with Dimension Research has established Pharmacovigilance Centre at Ojha Campus of Dow University. The aim of the establishment of this Centre is to improve patient care and safety in relation to the use of medicines and all medical and paramedical interventions, Improve public health and safety in relation to the use of medicines, Contribute to the assessment of benefit, harm, effectiveness and risk of medicines and to promote understanding, education and clinical training in pharmacovigilance.

Dr. Qaiser Waheed Chief Executive of Medisure Pharma was the
chief guest at the formal inauguration of Pharmacovigilance Center
established at DUHS. Photograph taken on this occasion shows him
sitting on the dais along with Prof. Masood Hameed Khan VC
DUHS and others.

Dr. Qaiser Waheed, Former Chairman PPMA & CEO Medisure Pharmaceuticals was the chief guest at the inauguration ceremony of the Pharmacovigilance. Speaking at the occasion he said that Dow University has taken a good initiative on this very important issue. It is a very important component and it is the need of the country because adverse drug reactions have implications not only for the patient, but for the entire health care system. There should be reporting system in the country regarding adverse effect of drugs. He also stressed the need for having a strong liaison between academia and industry that would guarantee a sustained track of progress in Pakistan.
Prof. Masood Hameed Khan, Vie Chancellor, DUHS in his address said that Dow University has developed a road map for the improvement of public health and safety in relation to the use of medicines. Dow Pharmacovigilance centre will be focusing on Patient, Pharmacovigilance will be the main aim of this centre through proper & on time monitoring of Adverse Drug Reactions (ADRs) and any other drug related issue.
Dr. Sumbul Shamim, Dean, Faculty of Pharmaceutical Sciences, DUHS said that the establishment of Pharmacovigilance Centre will enable us to learn more about why adverse drug events occur so that we can act to reduce patient deaths and negative health impacts.(PR)

© Professional Medical Publications. All rights reserved.